Development of Radiopharmaceuticals for Targeted Alpha Therapy: Where Do We Stand? [PDF]
Roger M Pallares, Rebecca Abergel
exaly +2 more sources
Macropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy. [PDF]
Echigo H +11 more
europepmc +1 more source
Targeted Alpha Therapy as a Multiscale Design Problem: From Radioactive Decay to Therapeutic Outcome. [PDF]
Lazić I +4 more
europepmc +1 more source
[<sup>225</sup>Ac]Ac-iPSMA Radiopharmaceuticals for Targeted Alpha Therapy: Design, Synthesis, and Preclinical Evaluation. [PDF]
García-Arce D +11 more
europepmc +1 more source
An analytical framework for efficient and precision-controlled Monte Carlo simulation of heterogeneous targeted alpha therapy microdosimetry. [PDF]
Zhu J, Cao S, Li X, Qi Y, Chen Z.
europepmc +1 more source
<sup>211</sup>At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges. [PDF]
Levillain H +16 more
europepmc +1 more source
The Second Nitrogen Fits: Development of Diazine-Based Macrocyclic Chelators to Stably Bind Radionuclides Used in Targeted Alpha Therapy. [PDF]
Blei MK +14 more
europepmc +1 more source
Targeted alpha therapy for glioblastoma. [PDF]
Kunikowska J +4 more
europepmc +1 more source
An integrative multi-omics landscape of multi-dimensional cellular stress and metabolic reprogramming in melanoma treated with targeted alpha therapy. [PDF]
Zhang J +14 more
europepmc +1 more source
Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy. [PDF]
Ramonaheng K +17 more
europepmc +1 more source

